These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26438105)

  • 1. A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.
    Agha Z; Iqbal Z; Kleefstra T; Zweier C; Pfundt R; Qamar R; VAN Bokhoven H; Willemsen MH
    Genet Res (Camb); 2015 Oct; 97():e19. PubMed ID: 26438105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complex microcephaly syndrome in a Pakistani family associated with a novel missense mutation in RBBP8 and a heterozygous deletion in NRXN1.
    Agha Z; Iqbal Z; Azam M; Siddique M; Willemsen MH; Kleefstra T; Zweier C; de Leeuw N; Qamar R; van Bokhoven H
    Gene; 2014 Mar; 538(1):30-5. PubMed ID: 24440292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal loss of 3q26.3-3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability.
    Millson A; Lagrave D; Willis MJ; Rowe LR; Lyon E; South ST
    Am J Med Genet A; 2012 Jan; 158A(1):159-65. PubMed ID: 22106001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intragenic deletions of NRXN1: three new case reports and a review of the phenotype].
    Galán-Sánchez F; Esteban-Cantó V; Blaya-Fernández P; Jadraque-Rodríguez R; Manchón-Trives I; Alcaraz-Más L
    Rev Neurol; 2015 Mar; 60(5):215-8. PubMed ID: 25710691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
    Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
    Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
    Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of speech and language phenotype in children with NRXN1 deletions.
    Brignell A; St John M; Boys A; Bruce A; Dinale C; Pigdon L; Hildebrand MS; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):700-708. PubMed ID: 30358070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
    Preiksaitiene E; Männik K; Dirse V; Utkus A; Ciuladaite Z; Kasnauskiene J; Kurg A; Kučinskas V
    Eur J Med Genet; 2012 Nov; 55(11):656-9. PubMed ID: 22842074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.
    Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T
    Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A boy with dysmorphic features, intellectual disability, and biallelic homozygous deletion in NRXN1.
    Holmquist P
    Clin Dysmorphol; 2015 Apr; 24(2):75-8. PubMed ID: 25486015
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of microdeletion of 19p13 with intellectual disability, hypertrichosis, synophrys, and protruding front teeth.
    Jelsig AM; Brasch-Andersen C; Kibæk M; Fagerberg CR
    Eur J Med Genet; 2012 Oct; 55(10):564-7. PubMed ID: 22750323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46,XX pure gonadal dysgenesis.
    de la Chesnaye E; Canto P; Ulloa-Aguirre A; Méndez JP
    Am J Med Genet; 2001 Jan; 98(2):125-8. PubMed ID: 11223847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.